# Angelo Michele Carella

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/angelo-michele-carella/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,268 |
| Field | Chronic Lymphocytic Leukemia Research |
| h-index | 58 |
| i10-index | 223 |
| Last Known Institution | Casa Sollievo della Sofferenza |
| OpenAlex ID | https://openalex.org/A5016794322 |
| ORCID iD | https://orcid.org/0000-0002-4967-4204 |
| Works | 546 |

## Researcher papers

- [Adapted Treatment Guided by Interim PET-CT Scan in Advanced Hodgkin’s Lymphoma](https://scholariq.org/papers/adapted-treatment-guided-by-interim-pet-ct-scan-in-advanced-hodgkin-s-lymphoma/)
- [Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial](https://scholariq.org/papers/brentuximab-vedotin-with-chemotherapy-for-cd30-positive-peripheral-t-cell/)
- [R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi](https://scholariq.org/papers/r-cvp-versus-r-chop-versus-r-fm-for-the-initial-treatment-of-patients-with/)

## Researcher topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Acute Myeloid Leukemia Research](https://scholariq.org/topics/acute-myeloid-leukemia-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)

## Researcher university

- [Casa Sollievo della Sofferenza](https://scholariq.org/institutions/casa-sollievo-della-sofferenza/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.